EBI-1051 | m-entrepreneurship.com

Product Name :
EBI-1051

Search keywords :
EBI-1051

drugId :
null

Target Vo:
Dual specificity mitogen-activated protein kinase kinase

Target Vo Short Name :
MEK

Moa_Name:
Dual specificity mitogen-activated protein kinase kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Hengrui Pharmaceutical Co Ltd

Active Company_Name :
Eternity Bioscience Inc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Jun Rabbit mAb Purity & Documentation
Foralumab medchemexpress
SIRT5 Antibody: SIRT5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to SIRT5. It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts